The FDA has given clearance to Adcentrx Therapeutics’ IND application for an antibody-drug conjugate (ADC) targeting solid ...
Thermo Fisher’s John Lesica discusses how mass spectrometry technology enables scientific breakthroughs in genomics and ...
The FDA has simultaneously granted approval to Astellas’ cancer drug Vyloy and to a companion diagnostic test developed by ...
A report of a case of motor neuropathy in a patient who received the vaccine last year has led the FDA to halt its ...
Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts ...
Wave Life Sciences reports that it has successfully carried out RNA editing in two patients with alpha-1 antitrypsin ...
MilliporeSigma has unveiled a large new biosafety testing facility in Rockville to meet the global demand. MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, ...
The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen or syringe. On Friday, Pfizer received FDA approval for Hympavzi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback